Ligand validation:2B8O

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 2B8O designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2B8O_GLC_L_501	1%	27%	0.357	0.537	1.65	1.31	2	1	0	1	100%	0.9167
8QQ6_GLC_A_203	46%	43%	0.101	0.833	0.65	1.53	-	2	1	0	100%	0.9167
2FIR_GLC_L_801	33%	34%	0.136	0.83	1.65	0.97	2	1	1	0	92%	0.9167
8QOD_GLC_A_203	33%	41%	0.14	0.815	0.62	1.63	-	2	0	0	100%	0.8433
3ELA_GLC_L_215	32%	41%	0.114	0.798	0.59	1.69	-	3	1	0	92%	0.9167
2AER_GLC_L_2001	16%	45%	0.168	0.748	0.93	1.17	-	1	1	0	92%	0.9167
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.65	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.